3D Health Solutions

Executive Summary

3D Health Solutions is a San Diego-based private company specializing in canine organoid cell culture for therapeutic nutrition and pharmaceutical screening. Founded in 2015, the firm develops organoid models of intestine, liver, pancreas, kidney, and heart, offering research services and co-development of custom models. These organoids enable more physiologically relevant in vitro testing for veterinary and potentially human drug development, reducing reliance on animal testing. The company operates at the intersection of digital health and medical devices, targeting the growing demand for advanced preclinical models. Despite limited public information on funding or revenue, its niche focus on canine organoids positions it uniquely in the organoid market, which is expanding due to the push for alternative testing methods. The company's platform could accelerate discovery of therapeutics for both companion animals and humans, given the translational relevance of canine models. Current efforts likely involve refining organoid protocols and securing partnerships with pharmaceutical and nutrition companies.

Upcoming Catalysts (preview)

• Q4 2026Strategic Partnership with Pharmaceutical or Animal Health Company40% success
• Q2 2026Publication of Peer-Reviewed Study Demonstrating Organoid Utility60% success
• Q1 2027Series A Funding Round to Scale Operations30% success